21 – 30 of 146
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2022
-
Mark
Pharmacoepigenetics in type 2 diabetes : is it clinically relevant?
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Type 2 diabetes classification : a data-driven cluster study of the Danish Centre for Strategic Research in Type 2 Diabetes (DD2) cohort
(
- Contribution to journal › Article
-
Mark
The highly expressed calcium-insensitive synaptotagmin-11 and synaptotagmin-13 modulate insulin secretion
(
- Contribution to journal › Article
-
Mark
Ex vivo and in vivo experimental investigation of miR-148a-3p as a novel therapy for insulin secretion and type 2 diabetes
2022) EASD, European Association for the Study of Diabetes, 58th annual meeting, In Diabetologia 65(Suppl 1).(
- Contribution to journal › Published meeting abstract
- 2021
-
Mark
Excess of glucocorticoids during late gestation impairs the recovery of offspring’s β-cell function after a postnatal injury
(
- Contribution to journal › Article
-
Mark
Serum aromatic and branched-chain amino acids associated with NASH demonstrate divergent associations with serum lipids
(
- Contribution to journal › Article
-
Mark
Differential DNA Methylation and Expression of miRNAs in Adipose Tissue From Twin Pairs Discordant for Type 2 Diabetes
(
- Contribution to journal › Article
-
Mark
Islet Autoimmunity and HLA Markers of Presymptomatic and Clinical Type 1 Diabetes : Joint Analyses of Prospective Cohort Studies in Finland, Germany, Sweden, and the U.S
(
- Contribution to journal › Article
-
Mark
Statin therapy is associated with epigenetic modifications in individuals with Type 2 diabetes
(
- Contribution to journal › Article
-
Mark
VPS39-deficiency observed in type 2 diabetes impairs muscle stem cell differentiation via altered autophagy and epigenetics
(
- Contribution to journal › Article